MyIBDDiet app: Participants in the Control crossover arm will be administered the intervention (using the app) for 30 days, and participants in the MYIBDDiet arm will use the app for 60 days.
Study summary
The goal of this clinical trial is to learn if an app designed for diet education can help patients with inflammatory bowel disease (IBD) learn about healthy eating.
The main question\[s\] it aims to answer are:
* Is the app easy to use?
* Is the app useful? Researchers will compare the diet app to see if it is better at teaching patients about a healthy diet than the standard information they may receive from their doctor.
Participants will be asked to use the app for one month and answer surveys to see how easy the app is to use and if it leads to healthier eating.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. ≥18 years
2. Able to provide informed consent
3. Established diagnosis of IBD determined by treating physician
4. Not in acute flare
5. Not pregnant
6. Willing and able to comply with all required study procedures
Exclusion Criteria:
1. Short bowel syndrome
2. High ostomy output
3. Intestinal strictures
4. Pregnancy or breastfeeding
5. Malnutrition (evaluated by Canadian Nutrition Screening Tool (CNST) )
6. Conditions requiring dietary restrictions (e.g. Celiac disease, kidney disease, diabetes, eosinophilic esophagitis)
7. Have other conditions that may require low fibre diet such as irritable bowel syndrome, gastroparesis.
8. Currently on a therapeutic diet
9. Already on a diet for IBD or using diet tool for IBD (e.g. Mediterranean or anti-inflammatory diet)
10. Active malignancy
Primary outcome measure(s)
Usability of MyIBDDiet App — Through study completion - 60 days Determined by MAUQ scores (mobile health app usability questionnaire) and semi-structured interview responses
Acceptability — Through study completion - 60 days Determined by TFA questionnaire (Theoretical Framework of Acceptability questionnaire) and semi-structured interview responses
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.